Cardiex

Overview

Cardiex Limited is an Australian medical technology company specializing in digital health solutions for assessing cardiovascular and vascular diseases. Publicly listed on the Australian Securities Exchange (ASX: CDX), the company is known for its proprietary SphygmoCor® vascular biosensing technology, which has FDA clearance and is utilized in over 4,500 installations globally at major medical and research institutions.

The organization develops noninvasive patient monitoring devices that measure arterial health through digital vascular biomarkers, such as central blood pressures and arterial stiffness. Their products include the SphygmoCor XCEL, for central aortic pressure waveforms, and the CONNEQT Pulse, a connected vascular biometric monitor for home and clinical use. These solutions are employed worldwide in clinical trials and healthcare systems to improve cardiovascular health outcomes via actionable data analytics. In 2024, the company achieved significant revenue growth, highlighting its expanding presence in the global medical technology sector.

Basic Information

Contact Details

• Phone: +61 2 9874 8761
• Website: cardiex.com
• LinkedIn: linkedin.com/company/cardiexlimited

Key Focus Areas & Initiatives

• Hypertension management
• Central blood pressure
• Arterial stiffness measurement
• Central arterial pressure waveform analysis
• Chronic kidney disease
• Unmanaged hypertension
• Prehypertension
• Vascular biomarkers
• Longevity
• Medical equipment manufacturing
• Digital biomarkers
• Arterial health in wellness programs
• Personalized care
• Home health monitoring
• Pharmaceuticals
• D2C
• Biomarker validation
• Research and development
• Medical equipment and supplies manufacturing
• Clinical trials
• Disease risk stratification
• B2C
• Digital health
• Cardiovascular disease detection
• Arterial health assessment
• Noninvasive monitoring
• Sphygmocor technology
• Digital health solutions
• Early detection
• Healthcare solutions
• Pulse wave analysis
• FDA-cleared technology
• Treatment monitoring
• B2B
• Vascular health in aging
• Vascular biomarkers for drug development
• Wearable cardiovascular devices
• Clinical trial support
• Clinical research tools
• Vascular phenotyping
• Cardiovascular health
• Vascular health in research
• Vascular health assessment
• Wearable devices
• Noninvasive patient monitoring
• Digital vascular biomarkers
• Wearable blood pressure sensors
• Personal health tracking
• Remote clinical trial data collection
• Vascular health monitoring
• FDA-approved medical devices
• Pharmaceutical trials
• Vascular stiffness measurement
• Services
• Remote health monitoring
• Noninvasive arterial stiffness measurement
• Arterial stiffness
• Health outcomes
• Arterial stiffness indices
• Healthcare
• Biomarkers
• Central aortic pressure
• Sphygmocor
• Predictive cardiovascular analytics
• Digital health for maternal health
• Remote patient monitoring
• Medical devices
• Vascular health in sports medicine
• Clinical research
• Vascular health in covid-19
• Drug development
• Academia
• Wellness
• Hypertension
• Renal disease
• Heart failure
• Maternal health
• Brain health
• Metabolic health
• COPD
• Men's health
• Sports medicine
• Hospital & health care
• Medical
• Research & development
• Health care
• Health, wellness & fitness
• Information technology & services

Technologies Used

• AI
• Atlassian Cloud
• Circle
• Cloudflare DNS
• Marketo
• Microsoft Office 365
• Outlook
• Remote
• Render
• Salesforce
• WP Engine

Affiliated Organizations & Regional Branches